[ALK重组的细胞癌:对三个病例的临床病理学分析]
X J Wang1, E J Liu1, M L Yang1
1Department of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhonghua bing li xue za zhi = Chinese journal of pathology
|September 8, 2025
概括
无细胞淋巴瘤激酶 (ALK) 重组的细胞癌 (RCC) 具有独特的分子特征,可以与其他RCC亚型混为一谈. 诊断需要免疫组织化学和基因重排测试.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 无细胞淋巴瘤激酶 (ALK) 重组的细胞癌 (RCC) 是一种罕见的亚型.
- 了解其临床病理学和分子特征对于准确诊断至关重要.
研究的目的:
- 调查ALK重组RCC.的临床病理学和分子遗传特征.
- 为了突出 TPM1-ALK 基因亚型的罕见病例.
主要方法:
- 分析了三个ALK重排的RCC病例,包括临床,病理和下一代测序 (NGS) 数据.
- 审查相关文献和患者的随访.
- 利用免疫组织化学和光 in situ 杂交 (FISH) 来检测基因重组.
主要成果:
- 三个病例 (年龄在29-44岁之间) 呈现为占用空间的病变.
- 确定了三个不同的ALK融合:KIAA1217::ALK,TPM1::ALK和EML4::ALK.
- 组织结构形态不同,可能与乳头RCC和TFE3重组的RCC混.
结论:
- 经ALK重组的RCC具有独特的分子特征.
- 免疫组织化学和基因重排测试对于确认诊断至关重要.
- 组织病理特征可以模仿其他细胞癌亚型.
更多相关视频
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
346
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
346
Urinary Tract Calculi III: Medical Management
196
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
196
Acute Kidney Injury III: Clinical Manifestations
828
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
828


